Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
Lumen Bioscience, Inc.
|
D | 2019-11-12 12:18:10 |
Amount To Be Raised
$26,052,323
Associated Brokers / Dealers
N/A
CIK Number
0001703612
Filed Document
0001703612-19-000001
Exclusions or Exemptions
506b
Accepted Date
2019-11-12 12:18:10
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Lumen Bioscience, Inc.
|
D | 2025-04-01 11:26:25 |
Amount To Be Raised
$23,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001703612
Filed Document
0001703612-25-000002
Exclusions or Exemptions
506b
Accepted Date
2025-04-01 11:26:25
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Lumen Bioscience, Inc.
|
D | 2022-06-29 10:18:01 |
Amount To Be Raised
$50,464,302
Associated Brokers / Dealers
N/A
CIK Number
0001703612
Filed Document
0001703612-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-06-29 10:18:01
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Lumen Bioscience, Inc.
|
D | 2023-09-15 09:07:01 |
Amount To Be Raised
$33,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001703612
Filed Document
0001703612-23-000001
Exclusions or Exemptions
506b
Accepted Date
2023-09-15 09:07:01
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Lumen Bioscience, Inc.
|
D | 2024-11-19 09:49:02 |
Amount To Be Raised
$18,345,489
Associated Brokers / Dealers
N/A
CIK Number
0001703612
Filed Document
0001703612-24-000001
Exclusions or Exemptions
506b
Accepted Date
2024-11-19 09:49:02
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
WASHINGTON
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|